Purdue Pharma reportedly in talks with DOJ to settle criminal, civil opioid probes

Purdue Pharma, maker of OxyContin, is in talks with the Justice Department to resolve criminal and civil probes related to its role in the opioid crisis, The Wall Street Journal reported Friday, citing people familiar with the matter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.